Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 13;10(4):e004660.
doi: 10.1136/rmdopen-2024-004660.

Immune checkpoint molecules performance in ANCA vasculitis

Affiliations

Immune checkpoint molecules performance in ANCA vasculitis

Paula Anton-Pampols et al. RMD Open. .

Abstract

Objective: The PD-1 axis promotes protection against autoimmunity. Immune checkpoint (IC) molecules performance in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) remains unknown. This study aims to assess the IC pathway's role in the AAV's pathophysiology.

Methods: We recruited 88 AAV from our centre as a discovery cohort (acute=42, remission=46) and 30 patients from another institution for external validation (acute=16, remission=14).Serum, urine and peripheral blood mononuclear cells (PBMCs) were collected. In vitro IC molecules production by lymphocytes was studied with and without MPO/PR3 antigen stimulus. Cell culture supernatant (SN) was obtained by centrifugation. PD-1, PD-L1 and PD-L2 concentrations were assessed in serum (s), urine (u) and SN of AAV and healthy controls (HC) using a multiplex assay. PD-1 and PD-L1's expression was analysed in six diagnostic kidney biopsies.

Results: uPD-1 and uPD-L2's concentration was lower in AAV than HC (p<0.0001, p=0.0075). Acute patients exhibited lower uPD-L2 levels compared with those in remission (p=0.036). Similarly, PBMCs showed reduced PD-1 production than HC (stimulated group p=0.04, unstimulated p=0.0074). Furthermore, patients with inflammatory renal lesions had fewer PD-1-positive interstitial cells/staining intensity compared with those with sclerotic lesions. Contradictorily, sPD-1 and sPD-L1's concentration was higher in AAV than HC (p=0.007, p<0.0001) with acute patients exhibiting elevated sPD-1 levels compared with those in remission (p=0.0051). Serum and urine findings were confirmed in the validation cohort.

Conclusions: Results in urine, SN and histology suggest IC pathway abolition during acute disease restored in remission and contribute to understand PD-1 axis's role in AAV proposing it as a new biomarker of disease activity.

Keywords: Autoimmunity; Systemic vasculitis; Vasculitis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1. (A) Serum levels of PD-1 in AAV and HC. (B) Mean of serum PD-1 in acute and remission patients and in HC. (C) Serum concentration of PD-L1 in AAV and HC. Values correspond to discovery cohort.
Figure 2
Figure 2. (A) Urine levels of PD-1 in AAV and HC. (B) Concentration of uPD-1 in acute, remission patients, and HC. (C) Mean of uPD-L2 in AAV and HC. (D) Concentration of uPD-L2 in acute, remission patients, and HC. Values correspond to discovery cohort.
Figure 3
Figure 3. Urine levels of PD-1 in the same group of patients in acute and then in remission phase. Values correspond to discovery cohort.
Figure 4
Figure 4. (A) Mean of PD-1 in supernatant cell culture of PBMCs (SNPD-1) in AAV and HC (unestimulated group). (B) Concentration of SNPD-1 in acute, remission patients, and in HC (unestimulated group). (C) Mean of SNPD-1 in AAV and HC in the MPO/PR3 antigen-stimulated group. (D) Concentration of SNPD-1 in acute, remission patients, and in HC in the MPO/PR3 antigen-stimulated group. Values correspond to discovery cohort. PBMCs, peripheral blood mononuclear cells; MPO, myeloperoxidase; PR3, proteinase 3.
Figure 5
Figure 5. This figure shows the presence of PD-1 in interstitial compartment in both sclerotic (A) and crescentic (B) biopsies.
Figure 6
Figure 6. Positivity of PD-1 interstitial cell and intensity PD-1 staining is shown as % of total patients.

References

    1. Jennette JC, Nachman PH. ANCA Glomerulonephritis and Vasculitis. Clin J Am Soc Nephrol. 2017;12:1680–91. doi: 10.2215/CJN.02500317. - DOI - PMC - PubMed
    1. Ooi JD, Chang J, Hickey MJ, et al. The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis. Proc Natl Acad Sci U S A. 2012;109:E2615–24. doi: 10.1073/pnas.1210147109. - DOI - PMC - PubMed
    1. Masutani K, Tokumoto M, Nakashima H, et al. Strong polarization toward Th1 immune response in ANCA-associated glomerulonephritis. Clin Nephrol. 2003;59:395–405. doi: 10.5414/cnp59395. - DOI - PubMed
    1. Nogueira E, Hamour S, Sawant D, et al. Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol Dial Transplant. 2010;25:2209–17. doi: 10.1093/ndt/gfp783. - DOI - PubMed
    1. Rimbert M, Hamidou M, Braudeau C, et al. Decreased numbers of blood dendritic cells and defective function of regulatory T cells in antineutrophil cytoplasmic antibody-associated vasculitis. PLoS One. 2011;6:e18734. doi: 10.1371/journal.pone.0018734. - DOI - PMC - PubMed

MeSH terms